A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer

被引：0
|
作者：
Ozge Gumusay
Laura A. Huppert
Mark Jesus M. Magbanua
Chiara A. Wabl
Michael Assefa
Amy Jo Chien
Michelle E. Melisko
Melanie C. Majure
Mark Moasser
John Park
Hope S. Rugo
机构：
[1] Acibadem University,Department of Medical Oncology, School of Medicine
[2] University of California San Francisco,Department of Laboratory Medicine
[3] Helen Diller Family Comprehensive Cancer Center,undefined
[4] UCSF,undefined
来源：
Breast Cancer Research and Treatment | 2024年 / 203卷
关键词：
Eribulin; Cyclophosphamide; Metastatic breast cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 204
页数：7
相关论文
共 50 条
  • [1] A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer
    Gumusay, Ozge
    Huppert, Laura A.
    Magbanua, Mark Jesus M.
    Wabl, Chiara A.
    Assefa, Michael
    Chien, Amy Jo
    Melisko, Michelle E.
    Majure, Melanie C.
    Moasser, Mark
    Park, John
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 197 - 204
  • [2] A phase Ib/II study of eribulin with cyclophosphamide (EC) in patients (pts) with advanced breast cancer (ABC).
    Gumusay, Ozge
    Renslo, Jonathan R.
    Wabl, Chiara A.
    Chien, Amy Jo
    Melisko, Michelle E.
    Majure, Melanie Catherine
    Rahmaputri, Siti D.
    Moasser, Mark
    Park, John
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer
    Tsutomu Iwasa
    Junji Tsurutani
    Satomi Watanabe
    Ryoji Kato
    Yutaka Mizuno
    Yasuyuki Kojima
    Tsutomu Takashima
    Nobuki Matsunami
    Takashi Morimoto
    Jun Yamamura
    Shoichiro Ohtani
    Yuko Tanabe
    Tetsuhiro Yoshinami
    Toshimi Takano
    Yoshifumi Komoike
    Kazuhiko Nakagawa
    BMC Cancer, 19
  • [4] Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer
    Iwasa, Tsutomu
    Tsurutani, Junji
    Watanabe, Satomi
    Kato, Ryoji
    Mizuno, Yutaka
    Kojima, Yasuyuki
    Takashima, Tsutomu
    Matsunami, Nobuki
    Morimoto, Takashi
    Yamamura, Jun
    Ohtani, Shoichiro
    Tanabe, Yuko
    Yoshinami, Tetsuhiro
    Takano, Toshimi
    Komoike, Yoshifumi
    Nakagawa, Kazuhiko
    BMC CANCER, 2019, 19 (01)
  • [5] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC).
    Truong, Thach-Giao
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [6] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC)
    Thach-Giao Truong
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Phase Ib dose-escalation study of eribulin in combination with capecitabine in patients with advanced/metastatic cancer
    Savulsky, C.
    Nasim, M.
    Plummer, R.
    Evans, J.
    Morrison, R.
    Anthoney, A.
    Haney, S.
    Madi, A.
    Johnston, C.
    Carter, D.
    Reydermann, L.
    Gopalakrishna, P.
    Wanders, J.
    Twelves, C.
    ONKOLOGIE, 2012, 35 : 153 - 154
  • [8] A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer
    Harding, James J.
    Zhu, Andrew X.
    Bauer, Todd M.
    Choueiri, Toni K.
    Drilon, Alexander
    Voss, Martin H.
    Fuchs, Charles S.
    Abou-Alfa, Ghassan K.
    Wijayawardana, Sameera R.
    Wang, Xuejing Aimee
    Moser, Brian A.
    Urunuela, Arantxa
    Wacheck, Volker
    Bendell, Johanna C.
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5202 - 5211
  • [9] A phase Ib dose-escalation study of eribulin mesylate in combination with capecitabine in patients with advanced/metastatic cancer
    Nasim, Muhammad Yaser
    Plummer, Ruth
    Evans, T. R. Jeffry
    Morrison, Rosemary
    Anthoney, David Alan
    Haney, Sophie
    Madi, Ayman
    Savulsky, Claudio Isaac
    Johnston, Claire
    Carter, David
    Reyderman, Larisa
    Gopalakrishna, Prashanth
    Wanders, Jantien
    Twelves, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Phase Ib study of selinexor and eribulin combination in advanced solid tumors and triple-negative breast cancer.
    Nelson, Blessie Elizabeth
    Saleem, Sadia
    Damodaran, Senthil
    Somaiah, Neeta
    Piha-Paul, Sarina Anne
    Moore, Julia Ann
    Yilmaz, Bulent
    Karp, Daniel D.
    Dumbrava, Ecaterina Elena
    Tsimberidou, Apostolia Maria
    Hong, David S.
    Ahnert, Jordi Rodon
    Booser, Daniel J.
    Ibrahim, Nuhad K.
    Conley, Anthony Paul
    Bhosale, Priya
    Hernandez, Cristhiam Mauricio Rojas
    Tripathy, Debu
    Naing, Aung
    Meric-Bernstam, Funda
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345